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Abstract

Author Manuscript

Poly(ethylene glycol)-conjugated polyethylenimine (PEG-PEI) is a widely studied cationic
polymer used to develop non-viral vectors for siRNA therapy of genetic disorders including
cancer. Cell lines stably expressing luciferase reporter protein typically evaluate the transfection
efficacy of siRNA/PEG-PEI complexes, however recent findings revealed that PEG-PEI can
reduce luciferase expression independent of siRNA. This study elucidates a cause of the false
positive effect in luciferase assays by using polymer nanoassemblies (PNAs) made from PEG,
PEI, poly-(L-lysine) (PLL), palmitate (PAL), and deoxycholate (DOC): PEG-PEI (2P), PEG-PEIPAL (3P), PEG-PLL (2P′), PEG-PLL-PAL (3P′), and PEG-PEI-DOC (2PD). In vitro transfection
and western blot assays of luciferase using a colorectal cancer cell line expressing luciferase
(HT29/LUC) concluded that 2P and 2P′ caused no luciferase expression reduction while
hydrophobically modified PNAs induced a 35-50% reduction (3P′< 2PD < 3P). Although cell
viability remained stagnant, 3P triggered cellular stress responses including increased membrane
porosity and decreased ATP and cellular protein concentrations. Raman spectroscopy suggested
that hydrophobic groups influence PNA conformation changes, which may have caused overubiquitination and degradation of luciferase in the cells. These results indicate that
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hydrophobically modified PEG-PEI induces cellular distress causing over-ubiquitination of the
luciferase protein, producing false positive siRNA transfection in the luciferase assay.

Graphical abstract

Keywords
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polyethylenimine

1. Introduction

Author Manuscript

Small interfering RNA (siRNA) can suppress mutated genes generating proteins which are
currently unable to be targeted by small molecule drugs and thus provide a new therapy for
genetic diseases including cancer (Davis et al., 2010; Lee et al., 2016; Wittrup and
Lieberman, 2015). However, siRNA often shows low transfection in vivo due to poor
delivery efficiency (Kim and Rossi, 2007). To improve delivery of siRNA to target sites,
polymer-based non-viral gene vectors have been developed, which include ionic complexes
between anionic siRNA and cationic polyethyleneimine (PEI) (Pandey and Sawant, 2016;
Patil and Panyam, 2009). siRNA/PEI complexes have achieved successful gene silencing in
various human cells in vitro, but they are unstable in the body (Wightman et al., 2001).
Polyethyleneglycol (PEG) is frequently used to stabilize siRNA/PEI complexes (Malek et
al., 2008; Nelson et al., 2013). The hydrophilic PEG chains surrounding siRNA/PEI
complexes can shield the particle charge and prevent protein adsorption. The siRNA/PEI
complexes can be further modified with hydrophobic excipients and other additives for
improving stability and fine-tuning release of siRNA (Zintchenko et al., 2008).

Author Manuscript

Based on this background, we developed siRNA delivery vectors by using polymer
nanoassemblies (PNAs) made from PEG, PEI, and hydrophobic pendant groups such as
palmitate (PAL) (Rheiner et al., 2015). PNAs are unimolecular assemblies of 30 nm
diameter particles having cationic polymer backbone to which PEG and a hydrophobic
moiety can be covalently conjugated. In previous studies, we reported that these PNAs
enhanced siRNA transfection in a human colorectal cancer HT29 cell line as functions of
PEG composition and PAL modification. These PNAs displayed siRNA transfection
efficiency comparable to PEG-PEI formulations developed by other research groups (Fella et
al., 2008; Liu et al., 2013) as well as commercially available transfection reagents such as
RNAiMAX. However, we have recently observed that PEG-PEI alters siRNA transfection
among product batches partially due to PEG compositions such as molecular weight,
substitution rate, and PEI contaminants (Rheiner and Bae, 2016). PEG-PEI also appeared to
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substantially change siRNA transfection efficiency before and after conjugation of
hydrophobic pendant groups, although the mechanism remained elusive (Rheiner et al.,
2015). However, further study of the hydrophobic modification to PEG-PEI also revealed
unexpectedly reduced luciferase expression in cells even in the absence of siRNA, called the
false positive effect.

Author Manuscript

The false positive effect on siRNA transfection is troubling in evaluating and predicting in
vivo performance of non-viral gene vectors made from PEG-PEI for future studies and
clinical applications. Usually, protein reporter assays are used to evaluate the transfection
efficiency of the siRNA/PEG-PEI complex, and luciferase is one of the reporter proteins that
offer a quick method for measuring siRNA-mediated gene silencing in living cells (Auld et
al., 2008; Bartlett and Davis, 2006; Helmfors et al., 2015). Luciferase protein activity is
correlated to the amount of luciferase protein in the cell following siRNA transfection by
measuring luminescence using luminogenic substrates (Choy et al., 2003). Luciferase has a
short half-life in live cells, less than 3 hours (Thorne et al., 2010), which makes it ideal for
determining long-term siRNA transfection efficiency. Any protein left within the cell after
incubation with siRNA/PEG-PEI complexes would be produced after the siRNA has had a
chance to take effect. However, this would not account for protein that has been denatured or
had its expression reduced by other means. If PEG-PEI can interfere with the luciferase
reporter assay this way, it would explain siRNA transfection efficiency varying among
product batches.

Author Manuscript

Another possible reason for inconsistent siRNA transfection of PEG-PEI is the cellular
stress responses triggered by siRNA/PEG-PEI complexes. Cellular stress responses can
induce multiple changes for the cell to better adapt to its environment, including altered
protein regulation (Harding et al., 2000) and increased protein removal (Ding et al., 2007).
Cell stress does not always appear as cytotoxicity nor is cytotoxicity required to induce
cellular protein regulation (Spriggs et al., 2010). As a result, false positive effects are
difficult to detect at a dosage showing no apparent cytotoxicity yet inducing cell stress. In
fact, even free siRNA considered non-toxic seems to induce cellular stress and display off
target effects (Lv et al., 2006; Xue et al., 2014), while little is known if and how PEG-PEI
would induce non-specific gene silencing during siRNA transfection without inducing
cytotoxicity. Therefore, understanding how PEG-PEI induces false positives is critically
important to improve polymer-based siRNA delivery.
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Our previous findings suggest that the addition of hydrophobic pendant groups to PNAs
would influence intracellular luciferase expression by either directly interacting with cells or
indirectly disrupting the protein synthesis process (Rheiner and Bae, 2016; Rheiner et al.,
2015). Therefore, this study elucidates the false positive effect of the hydrophobically
modified PEG-PEI PNA on siRNA transfection by using PNAs made from combinations of
PEG, PEI, poly(L-lysine) (PLL), palmitate (PAL), and deoxycholate (DOC): PEG-PEI (2P),
PEG-PEI-PAL (3P), PEG-PLL (2P′), PEG-PLL-PAL (3P′), and PEG-PEI-DOC (2PD) as
shown in Figure 1. This study focuses on the false positive effect presented by 3P and
determines the influence the PNA's components on the effect by changing aspects of its
composition. This included replacement of the long chain, flexible hydrophobic group PAL
with a smaller, more rigid hydrophobic group DOC and replacement of the branched PEI
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backbone with a more linear PLL chain. These PNAs (+/- siRNA) are characterized by in
vitro siRNA transfection, cell viability, toxicity and immunoblotting in a human colorectal
cancer cell line stably overexpressing luciferase (HT29/Luc). Raman spectroscopy is also
employed to investigate interactions between hydrophobic pendant groups conjugated to the
PNA core and compounds outside the particles. To investigate the cellular stress caused by
PNAs, assays determining total protein count, ATP concentration, and cellular membrane
porosity are used. Data obtained from these experiments are analyzed to determine the
effects of hydrophobic groups and polymer scaffold condensation on false transfection of
siRNA/PEG-PEI complexes.

2. Materials and methods
2.1 Chemicals

Author Manuscript
Author Manuscript

PEG (5 kDa, α-methoxy-ω-NHS ester activated) was purchased from NanoCS (New York,
NY). Branched PEI (bPEI), deoxycholate (DOC), N-hydroxy succinimide, 4dimethylaminopyridine, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride
(EDC HCl), palmitoyl chloride, resazurin sodium salt, sulforhodamine B based in vitro
toxicology assay kit (TOX6), and poly(L-lysine) (PLL, 30-70 kDa) were purchased from
Sigma Aldrich (St. Louis, MO). RNAiMAX, 4-12% NuPAGE Bis-Tris precast gels, HEPES
buffer (pH 8.0, 1 M), MES buffer (0.1 M, pH 5.0), RIPA buffer, pyridine, NuSieve GTG
agarose, dialysis membrane with molecular cut-off (MWCO) of 6-8 and 100 kDa, and other
organic solvents were purchased from Fisher Scientific (Waltham, MA). siRNA (5′GUUGGCACCAGCAGCGCACUU-3′) was purchased from GE Dharmacon (Lafayette,
CO). Opti-MEM was purchased from Life Technologies (Carlsbad, CA). Mitochondrial
ToxGlo™ assay kit and Bradford assay kit were purchased from Promega (Madison, WI).
McCoy's 5A, 0.05% trypsin/EDTA, and phosphate buffered saline (PBS) were from GE
Healthcare (Logan, UT). Fetal bovine serum (FBS) was purchased from Atlanta Biologicals
(Flowery Branch, GA).
2.2 Cell culture
HT29 human colon cancer cell line was purchased from American Type Culture Collection
(ATCC, Manassas, VA), and subsequently transfected to establish a cell-line stably
expressing firefly luciferase (HT29/Luc). Cells were cultured at logarithmic growth in a
humidified environment with 5% CO2 at 37 °C in McCoy's 5A media supplemented with
10% FBS according to ATCC recommendations.
2.3 Synthesis of PNAs

Author Manuscript

PNAs with a PEI backbone (2P and 3P) were synthesized from 25 kDa bPEI, 5 kDa NHSactivated PEG, and palmitoyl chloride as previously reported(Rheiner et al., 2015). In this
study, 2P was further modified with DOC through covalent conjugation to the PEI backbone.
Briefly, DOC was mixed with NHS, EDC, and DMAP in a 5:5:0.2 molar ratio in MES buffer
(0.1 M, pH 5.0). 2P was then added to the mixture in a 1:100 molar ratio of 2P:DOC at room
temperature. After 48 hours, the product was purified by dialysis and freeze drying to collect
2PD.

Int J Pharm. Author manuscript; available in PMC 2018 August 07.

Rheiner et al.

Page 5

Author Manuscript

PNAs with a PLL backbone (2P′ and 3P′) were prepared from 30-70 kDa PLL with 5 kDa
NHS-activated PEG and palmitoyl chloride as previously reported(Reichel et al., 2016). 2P′
was synthesized by reacting PLL with NHS-activated PEG in water:DMSO:pyridine mixture
at ratios of 2:1:1. The solution was mixed for 72 hours at room temperature. 2P′ was further
modified with palmitoyl chloride to create 3P′. 2P′ was dissolved in THF at 40°C and
palmitoyl chloride was added in a 1.1:1 molar ratio palmitate:2P′. After 15 minutes of
mixing, pyridine in a 2:1 molar ratio of pyridine:palmitate was added as a HCl scavenger.
The solution was reacted for additional 2 hours and purified by ether precipitation and
dialysis. The product was collected by freeze drying.

Author Manuscript

Purity and molecular weight uniformity of PNAs were determined by gel permeation
chromatography (GPC, Asahipak GF-7M column, 2 mg/mL, DMF mobile phase, 0.5 mL/
min, 40 °C). Diameter and surface charge were determined by dynamic light scattering
(DLS) and zeta potential measurements using Zetasizer Nano (Malvern, UK).
2.4 Gel electrophoresis
PNAs at varying concentrations (0-1 mg/mL) were mixed with 2 μg/mL siRNA solutions in
Opti-MEM at a 1:1 ratio and allowed to equilibrate for 30 minutes. Each mixture (20 μL)
was then loaded on to a 1% agarose gel and run at 100 volts for 60 minutes at room
temperature in TAE (Tris-Acetate 0.04 M, EDTA 0.001M) buffer. The gel was stained with
100 ng/mL ethidium bromide in a TAE buffer and rinsed 3 times with deionized water. The
gel was imaged using Typhoon GLA 9500 (GE Healthcare, Logan, UT) fluorescent imager
with an ethidium bromide filter set.
2.5 In vitro siRNA transfection
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Cells were plated at 5,000 cells per well into white opaque 96 well plates and incubated for
24 hours. After 24 hours, PNA solutions were prepared by adding 100 μL of 10 mg/mL PNA
solutions in optimem to 100 μL of 10 μg/mL siRNA solution or 100 μL of Opti-MEM.
Naked siRNA controls were created with 200 μL of siRNA solutions at 5 μg/mL. Opti-MEM
(200 μL) was used as the blank control. RNAiMAX controls were created by mixing 5 μL of
RNAiMAX with 95 μL of Opti-MEM and then either 100 μL of Opti-MEM or 100 μL of 10
μg/mL siRNA solution for the empty RNAiMAX control or siRNA-loaded RNAiMAX
control, respectively. Complexes were formed by incubating the mixtures for 30 minutes at
room temperature, except the RNAiMAX control that was incubated for 5 minutes as
instructed by the manufacturer. From each well, 20 μL of solutions were replaced with their
respective complex solutions or controls (n = 6) to yield 1 mg/mL of PNA and 1 μg/mL
siRNA in the well. The plate was incubated for 72 hours at 37°C and then read for
bioluminescent intensity using GloMax luminometer. The substrate was 100 μL of 0.1
mg/mL luciferin solution in PBS. Luminescent intensity was collected for 10 seconds and
reported as percentage of luciferase activity with respect to control wells. The data was
normalized to cell viability (resazurin assay conducted in section 2.6) to account for cell
death in the reduction of the luciferase signal.
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Four cell viability assays were used in this study to consider different aspects of cell health.
Mitochondrial activity was measured by resazurin. Plates used for transfection (see section
2.5) had 10 μL of a 1 mM resazurin solution was added to each well and incubated for 3
hours. The plate was read on SpectraMax M5 (Molecular Devices) fluorescent plate reader
at excitation/emission of 560/590 nm. The readings were subtracted from blank controls and
reported as percentage of viable cells.

Author Manuscript

Sulforhodamine B assay measured total protein concentration in live cells. Cells were seated
and dosed with empty 3P based on the method described in section 2.5. After 72 hours post
dosage, cells were fixed with 30 μL/well of provided TCA solution at 4°C for 1 hour. After
media removal and air drying, 20 μL/well of sulforhodamine B solution was added and
allowed to stain for 30 minutes. The stain was then removed, washed with 1% acetic acid
solution, and air dried. Then, 100 μL/well of 10 mM Tris base solution was added and
incubated for 5 minutes at room temperature. Absorbance was measured at 565 nm
excitation and 690 nm emission with a SpectraMax M5 (Molecular Devices) fluorescent
plate reader. The absorbance at 690 nm is subtracted from the absorbance at 565 nm to
determine percent viable cells with respect to controls.

Author Manuscript

Cell membrane integrity and mitochondrial activity of cultured cells were measured with the
Mitochondrial ToxGlo assay kit per manufacturer's instruction. HT-29 cells not expressing
luciferase were seated and dosed with empty 3P based on the method described in section
2.5. After 72 hours post dosage, 20 μL/well of the provided bis-AAF-R110 solution was
added to the wells of the plate and incubated at 37°C for 30 minutes. Fluorescence was
measured at excitation/emission of 495/520 nm using a SpectraMax M5 (Molecular
Devices) fluorescent plate reader. Then, 100 μL/well of the provided ATP detection reagent
was added to the plate and read for luminescence with GloMax luminometer. The values
were compared to their respective controls (untreated wells) and reported as percentages of
the control.
2.7 Western blotting for luciferase expression

Author Manuscript

Cells were plated at 50,000 cells/well in a 12 well clear plate. 24 hours later, 200 μL of
media were replaced with 200 μL of Opti-MEM, empty PNAs, or siRNA/PNA complexes.
After a 72-hour incubation at 37°C, cells were lysed with a RIPA buffer and assayed for
protein content with a Bradford assay kit (Promega). Then, 100 μg of protein for each
sample were subjected to electrophoresis through a 4-12% NuPAGE Bis-Tris precast gel.
Afterwards, the proteins were transferred to a nitrocellulose membrane. Primary antibodies
used to treat the membranes were anti-luciferase and anti-beta-actin (Cell Signaling
Technologies). After washing, the membranes were exposed to IgG-horseradish peroxidase
conjugate secondary antibodies for 1 hour and developed with an ECL Western blotting
substrate (Promega and SCBT). To detect the slow-migrating firefly luciferase protein in
SDS/PAGE, cells were incubated with the 2P, 2P′, 3P, and 3P′ for 72 h as described above,
and further incubated in the presence of MG132 (40 μM) for 6 h. The protein extracts were
run in SDS/PAGE and transferred to PVDF membranes, which were cut above the intact
firefly luciferase protein to exclude the intact protein in the membrane, and blotted with the
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2.8 PNA-protein and PNA-substrate interaction analyses

Author Manuscript

rabbit polyclonal anti-firefly luciferase antibody (Promega). The blot was developed with
SuperSignal West Femto (Pierce, Thermofisher), and the signals were analyzed in
ChemiDoc Imaging Systems (Bio-Rad).

2.9 Raman spectroscopy

First, 20 μL of 10 mg/mL PNA solutions or RNAiMAX solution were incubated for 10
minutes in wells of a white 96 well plate (n = 6). Each well contained 80 μL/well of PBS
with luciferase proteins to obtain 1 mg/mL PNA and 5 ng/mL of luciferase. Then, 100 μL of
0.1 mg/mL luciferin solution in PBS were added to each well and read using GloMax
luminometer with an integration time of 10 seconds. Similarly, 2 mL of 10 mg/mL PNA
solutions or RNAiMAX solution were mixed for 30 minutes with 8 mL of 0.125 mg/mL
luciferin solution. Then, 100 μL of this solution was then injected using GloMax
luminometer into each well of a white 96 well plate containing 100 μL/well of 5 ng/mL
luciferase in PBS. Luminescence was measured and integrated for 10 seconds. Data is
reported as RLU values.

Author Manuscript

Raman spectroscopy was conducted in the solid state using a Nicolet iS 50 FTIR with a
Raman module (Thermo Fisher Scientific, Waltham, MA). The samples were prepared on a
48 well metal plate with duplicate wells containing either single components (PEG, PAL, or
PEI), physical mixtures of components (PEG/PEI, PEG/PAL, PEI/PAL), or complete PNAs
(2P or 3P). Duplicate wells allow for one well to contain components or PNAs alone or with
siRNA. For analysis of single components, 100 μL of a 10 mg/mL solution of each
component and an additional 100 μL of water was added to the well. For physical mixtures
of components, 100 μL of a 10 mg/ml solution of each component was added to the well
combination with an additional 100 μL of another component. Then, 1 μL of a 1 mg/mL
siRNA solution or 1 μL of water was added to respective wells of components or PNAs. The
loaded metal plate was stored at room temperature for 30 minutes to allow samples to
interact with siRNA. The plate was then transferred to dry ice and the samples were frozen.
The frozen samples were then freeze dried overnight and then read on the Raman. Data was
collected and deconvoluted using the Omnic Spectra Software suite (Thermo Fisher
Scientific, Waltham, Mass.).

3. Results
3.1 PNA synthesis and characterization

Author Manuscript

Total five PNAs (2P, 3P, 2PD, 2P′, and 3P′) were synthesized to investigate the effects of
backbone composition (PEI vs. PLL) and hydrophobic groups (PAL vs DOC) on siRNA
transfection. Both PEI-based (2P and 3P) and PLL-based (2P′ and 3P′) PNAs were uniform
in size and contained no impurities as confirmed by GPC analysis (Figure 2 A and B). DLS
measurements showed that all PNAs were 30-35 nm in diameter. Zeta potential
measurements had all particles with neutral surface charge. The minimum siRNA
complexation ratio (mass of PNA/mass of siRNA) for each particle was determined in
Figure 2 C and D. 3P had the largest ratio of 1 mg per 1 μg of siRNA. Additionally, 2P
showed significantly lower cytotoxicity than naked PEI (Figure 3A) and all particles showed
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negligible toxicity at a concentration of up to 5 mg/mL, except 3P reducing cell viability by
15 % (Figure 3B). To ensure that polymers forming complexes with 1 μg/mL siRNA show
no cytotoxicity in in vitro studies, we treated cells with 1 mg/mL of polymer, which is 5
times lower than concentrations showing any significant reduction in cell viability (Figure
3).
3.2 PNAs inducing reduction of luciferase protein expression

Author Manuscript

Approximately 38% of the HT29 cells stably expressed a firefly luciferase protein (based on
fluorescence microscope imagery, not shown), which was sufficient to quantify
bioluminescence of cells treated with anti-luciferase siRNA. However, unexpected
reductions in luciferase expressions (or false positives in siRNA transfection) were observed
in cells dosed with 1 mg/mL PNAs with and without anti-luciferase siRNA for 72 hours
which mimics conditions from the previous study (Rheiner et al., 2015). Figure 4A shows a
reduction in luciferase protein of HT29 close to 50% when treating cells with 3P, and near
40% when treated with 2PD regardless of the presence of siRNA. Western blots also show a
reduction in cellular luciferase concentration after treatment with 2PD and 3P (Figure 4B).
2P remains unable to reduce the luciferase expression, which is consistent with previous
findings. These results confirm that both PAL and DOC induce false positive effects.
Replacing the PNA backbone with PLL from PEI yielded similar results (Figure 5). 2P′ was
unable to reduce luciferase expression just as 2P. However, 3P′ reduced the expression of
luciferase by approximately 25% regardless of the presence of siRNA. Interestingly, 3P′
shows a false positive but not to the same extent as 3P.
3.3 PNA-protein and PNA-substrate interactions

Author Manuscript

Although the luciferase assay is a good indicator of protein activity within the cell, it cannot
distinguish between proteins that have lost activity and proteins that decrease in number.
Previous western blots confirmed a reduction in luciferase protein after incubation with 3P,
yet contributions to loss of luciferase activity from interference with PNAs still need to be
considered. As shown in Figure 6A, no reduction in luciferase activity was observed when
luciferase was incubated with 3P. However, 2P reduced the activity slightly though this was
not observed during the in vitro luciferase assays. When PNAs were incubated with luciferin
before adding luciferase neither particle interfered with the luciferase activity (Figure 6B).
These results indicate that the PNAs with hydrophobic moieties do not reduce luciferase
activity through direct interactions with luciferase or luciferin.
3.4 Raman spectroscopy

Author Manuscript

To better understand how palmitate could interact with other cellular components and induce
cell stress, Raman spectroscopy of 2P, 3P, and each of their individual components was
conducted (Figure 7). Each polymer was allowed to interact with siRNA and the changes
between spectra with and without siRNA were compared. Naked siRNA does not appear on
the spectra at the concentration used in this experiment and therefore any changes between
spectra can be attributed to vibration changes of the polymers. Vibrational changes are
induced either through stabilizations or conformational changes of the chemical bonds in the
polymers. A chemical interaction can induce either stabilizations or conformational changes
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and therefore vibrational changes on the Raman spectra indicate some form of interaction
between siRNA and the tested polymers.
Based on the Raman spectra, interactions of siRNA with PEG or PAL were minor but the
interaction between PEI and siRNA was more pronounced. Physical mixtures of PEI/PAL
and PEG/PAL showed unexpected interactions with siRNA. PEG/PAL showed a large
change in vibrational intensity although neither component showed significant interaction
with siRNA on their own. PEI/PAL increased its vibrational intensity, which indicates that
the polymers are more mobile in the presence of siRNA. Raman spectra of 2P and 3P with
siRNA slightly changed after the addition of siRNA although the exact influence of PAL in
these interactions could not be determined.
3.5 Evaluation of cell stress caused by 3P

Author Manuscript

Cytotoxicity assays, Figure 4A, initially showed little toxicity by the PNAs. However, this
assay does not account for all factors that affect cell health. Changes in ATP content, total
protein amount, and cell membrane porosity were also investigated to determine the
presence of cellular stress. Figure 8 shows differences among these cytotoxicity assays. 3P
did not have a significant impact on redox activity in the cell but ATP and total protein levels
in the cells greatly decreased. Additionally, membrane porosity increased with incubation of
3P.
3.6 High molecular-weight firefly luciferase formation induced by PNA

Author Manuscript

It was considered that luciferase may be increasingly ubiquitinated and degraded in the cell
after PNA treatment. Western blotting of cells dosed with PNAs visualized luciferase
proteins and their molecular weights. Higher molecular weight luciferase likely corresponds
to polyubiquitinated luciferase which is degraded by the proteasome. Western blot analysis
of cells dosed for 72 hours with 2P, 2P′, 3P, and 3P′ and an additional 6 hours with MG132
proteasome inhibitor confirmed the presence of both normal and high molecular weight
luciferase (Figure 9). The proteasome inhibitor prevents the degradation of ubiquitinated
luciferase so that it can be visualized on the blot. Figure 9A shows reductions in luciferase
concentration, comparable to what is previously seen with 3P and 3P′, and displays little
effect by the proteasome inhibitor MG132. Initially high molecular weight luciferase
decreased in cells dosed with 3P and 3P′, but these bands increased upon addition of the
proteasome inhibitor (Figure 9B) indicating that these bands may be ubiquitinated. All
PNAs induced an increase in molecular weight of luciferase while 3P and 3P′ caused the
highest increase in this band comparatively. This indicates that 3P and 3P′ increase
ubiquitination of luciferase and they may also increase proteasome activity.

Author Manuscript

4. Discussion
We previously investigated PEG-PEI PNAs to improve siRNA delivery by modulating
complex stability through addition of palmitate, a hydrophobic moiety (Rheiner et al., 2015).
However, we have recently observed an siRNA-independent reduction of luciferase in cells
treated with PEG-PEI only after it has been modified with hydrophobic pendant groups
(Figure 4), referred to as the false positive effect. Such false positives might be detrimental
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in developing siRNA-based therapeutic options that require specific gene silencing for
targeted gene therapy. Additionally, these false positives occur without inducing cytotoxicity
that is a common sign of an abnormal cell response. Therefore, this study further
investigated potential mechanisms for the unexpected protein reduction by using PNAs made
from PEG-PEI with different hydrophobic pendant groups (PAL vs DOC) and polymer
backbone (PEI vs PLL).
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PNAs with differing hydrophobic moieties may influence the false positive effect differently
due structural differences. PNAs with rigid bile acid DOC (2PD) were investigated in
addition to PNAs with flexible fatty acid PAL (3P) as these hydrophobic groups are
structurally different. It was observed that 2PD resulted in less luciferase activity relative to
3P. However, it is unknown if this is due to decreased protein activity or cellular
concentration of luciferase because the assay does not differentiate between the two
conditions. To observe any loss of activity of luciferase due to PNA interaction, PNAs were
incubated with free luciferase protein or free luciferin substrate before addition of the other
component. Since protein incubation with 3P did not reduce the activity of luciferase, the
protein concentration should be lower in the cell and this was supported by western blotting.
This determined that the false positive transfection is induced by other hydrophobic moieties
and causes a lowered luciferase concentration.

Author Manuscript

The composition of the cationic backbone is another factor that may alter the false positive
effect by changing the PNAs secondary structure formation. The secondary structure of a
nanoparticle can influence the location of components within its core by changing how the
polymer condenses. PEI, a branched cationic polymer, was replaced by PLL, a more linear
cationic polypeptide, the create 2P′ and 3P′. These particles were similar in size and surface
charge to PEI based PNAs. The false positive effect was observed in 3P′ but to a lesser
extent than 3P. While changing the backbone structure mildly decreased the false positive
effect, it did not eliminate it. This indicates that the backbone structure is not as influential
as hydrophobic moiety in causing the false positives effect.

Author Manuscript

Raman spectroscopy offers another method to better understand PALs influence on false
positives by examining PAL's influence on PNA interaction. Raman spectroscopy measures
the vibrational energy of chemical bonds in a compound which can determine the influence
of PNA components on interactions with other compounds (Dootz et al., 2006; Romero et
al., 2010; York et al., 2003). These bond vibrations are unique and will change by either
shifting their energy spectrum or reducing signal intensity depending on interactions or
conformation of PNA components. Raman spectroscopy showed the differences in
vibrational energies after the interaction between siRNA and components of 3P, their
physical mixtures, and finally the complete PNAs. Initially, the Raman spectra detected
minor intensity reductions when siRNA interacted with each separate component of 3P
(PEG, PEI, and PAL). However, physical mixtures of components containing PAL (PEI/PAL
and PEG/PAL) showed larger vibrational intensity changes than the components. The
changes indicated that the PAL had influence over the conformation or interaction of the
components with siRNA. When each component is tethered in a PNA, some vibrational
changes are more intense when siRNA interacts with the PNAs. Even if the PAL and siRNA
are not directly interacting, the Raman spectra show that PAL should influence the Raman
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shifts observed. Therefore, PAL may influence the way 3P condenses around the siRNA,
which would further alter the particle conformation and disrupt vibrational energies. While
this is not a strong correlation, it gives evidence that the inclusion of PAL in the PNA does
influence the PNA condensation when it comes in to contact with other compounds.
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PAL influence over PNA interaction with cellular components could induce cell stress
without significant cytotoxicity. Cell stress is a condition where cell metabolism, protein
concentration, and gene expression may be altered to combat cellular damage or sudden
changes in environment (Spriggs et al., 2010). Though cell stress often leads to cytotoxicity,
it can still be present without inducing significant toxicity and can be overlooked by some
viability assays. The viability assay used in conjunction with the transfection assays was a
resazurin based assay which is a widely-used method for determining cell viability in
mammalian cells (O'Brien et al., 2000). Resazurin is reduced to a fluorescent molecule,
resorufin, in the cell indicating redox activity which correlates with cell viability. This assay
focuses on cell metabolism and does not account for other indicators of cell health. Three
other markers of cell health were examined to obtain a more complete picture of cell health:
total protein concentration in cells, ATP production, and membrane porosity. Cells dosed
with 3P exhibited less total protein, lower ATP concentration, and more porous membranes
than those of the control group. Lowered total protein production does indicate cell death
has occurred but the amount of cell death indicated in Figure 8 would not completely
account for the reduced luciferase concentration. More porous membranes and lowered ATP
production (Tiwari et al., 2002) are significant signs of cell stress and adds further evidence
that 3P is not completely harmless to the cell. These factors support that 3P has an adverse
effect on the cells that leads to cell stress but the specific cause of the stress is uncertain.
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Core components of hydrophobically modified PNAs have been known to cause cell stress
in other formulations which may give possible mechanisms to cell stress induced by 3P. Free
PAL can cause cell stress and autophagy through endoplasmic reticulum stress (Cunha et al.,
2008), free radical formation (Koyama et al., 2011), toll like receptor activation (Suganami
et al., 2006), caspase mediated apoptosis (Listenberger et al., 2001), and glucose metabolism
reduction (Alcazar et al., 1997). Lipids attached to cationic head groups have been shown to
increase enzyme inhibition inside cells, a result of both cationic and lipophilic regions
(Aberle et al., 1998). Additionally, cationic polymers and some lipids can reduce protein
expression and increased protein degradation due to cell stress (Hollins et al., 2007; Ishii et
al., 2015; Omidi et al., 2003; Omidi et al., 2005). However, it should be noted that these cell
stress mechanisms are due to free components either alone or removed from their respective
nanoparticles. The purification methods used during PNA synthesis removed all free
hydrophobic groups and the hydrophobic moieties to the PEI backbone are stable so that no
free hydrophobic groups would be present in formulation. However, the chemically
conjugated hydrophobic moieties may be able to interact with cellular components in a
similar way to these free hydrophobic groups. Although these formulations differ from
PNAs, they present possible mechanisms by which hydrophobic moieties can cause cellular
stress through interaction with the cell.
3P induced cell stress may produce false positives by causing fluctuation of cellular protein
concentration, including luciferase. One mechanism of protein reduction in the cell is
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increased ubiquitination of proteins, which increases their proteasome degradation. Protein
ubiquitination occurs normally in the cell as part of the ubiquitination-proteasome pathway
but is increased in times of stress or when certain pathways are activated, such as autophagy
(Kirkin et al., 2009). Western blotting confirmed an increase in the molecular weight of
luciferase inside cells dosed with hydrophobically modified PNAs. Although this is not
direct evidence of luciferase ubiquitination, an increase in molecular weight of a protein can
often be the result of ubiquitination. The increase in the high molecular weight luciferase
band after proteasome inhibition gives further evidence that this is ubiquitinated luciferase.
As previously mentioned, hydrophobic groups may cause oxidative and endoplasmic
reticulum stress which has been shown to increase protein ubiquitination (Shang and Taylor,
2011; Yoshida, 2007). These stresses can also lead to regulated cell death which would
increase protein ubiquitination (Orlowski, 1999) as well. We emphasize that this process is
one plausible mechanism leading to false positive effects shown in our study and there might
be a more complicated interplay among toxicity, cell stress, and nanoparticle compositions.
Although the exact cellular mechanism causing increased ubiquitination is unknown, this
gives a better understanding of the interactions hydrophobically modified PNAs are inducing
in the cell.
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Based on the results of this study, we propose that the hydrophobically modified PNAs can
interact with cellular components by allowing hydrophobic groups to influence PNA
interactions with compounds outside of the nanoparticle. The data suggests that the
hydrophobic group is most influential, compared with backbone structure, in generating the
false positive. To achieve this, the hydrophobic component would be required to interact
near the surface of the PNA. PNAs exist as a single polymer, core/shell systems regardless of
the presence of siRNA, as evidenced by our previous study (Rheiner and Bae, 2016), and
empty PNAs should behave similarly to complexed PNAs. Hydrophobic moieties are housed
in the core of the PNA and the PEG shell should prevent their interaction while the PNA
maintains its secondary structure, or folded state. However, PNAs could be in a state of
equilibrium between the folded and unfolded states. The addition of PEG and PAL will drive
the equilibrium toward the folded state, forming a core/shell environment, but a small
percentage of the unfolded state will persist. This unfolded state may allow the PAL to
interact with cellular components, possibly causing endoplasmic reticulum stress.
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While this mechanism accounts for interactions outside the PNA, the PNA may additionally
interact with cellular components reaching its core. PNAs may also capture molecules
needed for cellular metabolism, such as ATP or other important cellular process cofactors,
which are small enough to enter the particle core. Entrapping these important cellular
molecules would have induced cellular stress causing non-specific reduction in luciferase. In
particular, 3P has both cationic and hydrophobic regions, and thus they can attract
coenzymes like ATP through both ionic and hydrophobic interactions. After the coenzyme is
charge neutralized, they may be entrapped in PNAs further strongly by hydrophobic
interactions. We previously confirmed that PNAs altered drug release patterns in the
presence of hydrophobic excipients outside of the PNAs, yet these hydrophobic excipients
were not found to enter the PNA but weakly bound the surface of the PNA (Reichel and Bae,
2016). Therefore, binding of cofactors to the surface or inside the PNA is possible and can
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cause cell stress. Further investigation into these mechanisms is ongoing and will be
reported in future studies.

5. Conclusions
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This study confirmed the false positive siRNA transfection in the luciferase reporter assay,
induced by siRNA/PEG-PEI complexes modified with hydrophobic pendant groups. The
false positive effect was not limited to a specific hydrophobic moiety, but could be triggered
by many other factors such as cationic polymer composition, conformation, and complex
stability. Changes in core condensation based on backbone linearity reduce the false positive
effect but are unable to eliminate it. The hydrophobic moiety appeared to cause cellular
stress leading to over ubiquitination and degradation of luciferase. The exact cellular
mechanism by which the effect is induced remains elusive but these results clearly
demonstrate that hydrophobic core components of PEG-PEI based siRNA delivery vehicles
can induce false positive siRNA transfection in luciferase reporter assays. These findings
provide a valuable insight into designing non-viral gene vectors made from PEG-PEI and
potentially other types of cationic polymers.
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PLL

Poly-L-Lysine

PEG

Poly(ethylene glycol)

PAL

Palmitate

DOC

Deoxycholic Acid

2P

PEG-PEI

2P′

PEG-PLL

2PD

PEG-PEI-DOC
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PEG-PEI-PAL

3P′

PEG-PLL-PAL
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Figure 1. PNA scheme
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Progression of PNA development from backbone polymer (PEI or PLL) to subsequent
random covalent modification with PEG and hydrophobic moiety (DOC or PAL) and finally
their complexes with siRNA. *: Palmitate was replaced with deoxycholic acid (DOC) to
generate PEG-PEI-DOC (2PD).
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Figure 2. Characterization of PNAs

Gel permeation chromatography (GPC) spectra shows particle uniformity and purity of PEI
based PNAs (A: 2P in black and 3P in green) and PLL based PNAs (B: 2P′ in black and 3P′
in green). Gel electrophoresis was run for PEI based PNA/siRNA mixtures (C) and PLL
based PNA/siRNA mixtures (D) with 72 nM siRNA and varying concentrations of PNA.
Bands retained in the well indicate complexes have been formed and the lowest amount of
polymer needed to form complexes with siRNA is indicated by a black box.

Author Manuscript
Int J Pharm. Author manuscript; available in PMC 2018 August 07.

Rheiner et al.

Page 19

Author Manuscript
Author Manuscript
Author Manuscript

Figure 3. Toxicity of TNAs at a high concentration

A: Viability versus concentration curves of naked PEI (closed circle) and 2P (open circle)
after 72-hour incubation. B: Resazurin viability assay of empty TNAs at 5 mg/mL after 72hour incubation. * represents significant difference from the untreated control condition
(p<0.01).
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Figure 4. PNA in vitro luciferase reduction

A: Luminometric assay of luciferase (left) and mitochondrial activity based viability assay
(right) after 72-hour incubation with each particle. Solid bars represent each condition
without siRNA and striped bars represent condition with 1 μg/mL anti-luciferase siRNA. B:
Western blotting results after 72-hour incubation with loaded and unloaded 3P and 2PD
including an untreated control. * represents significant difference from the untreated control
condition (p<0.01).
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Figure 5. PLL Based PNA in vitro luciferase reduction

luminometric assay of luciferase (left) and mitochondrial activity viability assay (right) after
72-hour incubation with each particle at a concentration of 1 mg/mL. Grey bars represent
each condition without siRNA and striped bars represent condition with anti-luciferase 1
μg/mL siRNA. * represents significant difference from the untreated control condition
(p<0.01).
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Figure 6. Direct PNA/protein and PNA/substrate interactions

A: Interaction between PNAs and Luciferase protein was observed by incubating the protein
and PNA together for 10 minutes. Then luciferin solution was added to the well and a
luminescence reading was taken. The readings were normalized to the control well of
luciferase protein alone. B: PNA and Luciferin (substrate to luciferase) direct interaction was
observed by 30-minute incubation of PNA and Luciferin before an injection of luciferase
solution was added to the well. A luminescence reading was taken and the values normalized
to the control well which did not contain PNAs. * represents significant difference from the
untreated control condition (p<0.01).
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Figure 7. Raman spectroscopy of PNAs and their components
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Raman spectrographs of each component of PNAs (top row), binary physical mixture of
PNA components (middle row), and chemically conjugated PNAs (bottom row).
Spectrograph A is the raw form of the Raman shift and spectrograph B is the deconvoluted
raw spectra. Red lines indicate components or PNAs mixed with siRNA and black lines
indicate components or PNAs alone.
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Figure 8. Alternative cell health markers after incubation with 3P

Four cell viability markers were examined to elucidate cell stress occurring within cells after
72-hour incubation with empty 3P complexes at 1 mg/mL. Mitochondrial activity was
analyzed using the resazurin assay, total protein count was determined using the
Sulforhodamine B assay, total ATP count was done using a luminometric assay in HT29
cells that did not express luciferase, and membrane porosity was analyzed by an assay that
measured the cells ability to reduce Bis-AAF-R110 which can only be reduced from inside
the cell. Values were plotted as the log of the ratio between the cells dosed with 3P and the
control cells. Values statistically different from their control condition are denoted by *
(p<0.01).
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Figure 9. PNA induced ubiquitination of luciferase

Western blots detailed the expression of (A) luciferase, and (B) high molecular weight
luciferase after 72h dosage of PNAs in HT-29-luc cells. Additionally, cells were dosed as
indicated with MG132 proteasome inhibitor for 6h before cell lysis. Cellular expression of
luciferase was compared with beta tubulin. * denotes that the column is significantly
different from the no particle, no MG132 condition (p<0.01).
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